2 results
Approved WMORecruiting
- To evaluate the treatment efficiency by time to progression according to RECIST 1.1
Approved WMOCompleted
Primary Objectives:* To determine the efficacy of daily oral DP13 treatment (all dose arms combined) to decrease the plasma aldosterone-to-renin ratio (ARR) from baseline in patients with primary aldosteronism (PA)* To determine the efficacy of…